Company Directory > CRO > Marin Biologic Laboratories
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Marin Biologic Laboratories and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Marin Biologic Laboratories (MarinBio) is a premier contract research organization (CRO) and laboratory specializing in cell-based assays, immunoassays, and small-scale biologics manufacturing. With over 30 years of experience, the company provides comprehensive support for drug discovery, pre-clinical, and clinical development, including IND/BLA applications and commercialization. MarinBio serves a diverse range of clients, from large pharmaceutical companies to small, virtual bioscience startups. The company is known for its collaborative approach, where scientists work directly with clients to provide customized solutions in fields such as gene therapy, immunotherapy, and targeted protein degradation, all while maintaining compliance with FDA and EU cGMP/GLP standards.
CLASSIFICATION
Company Type:CRO
Industry:CRO
Sub-Industry:Biologics Testing & Contract Research
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:N/A (Service Provider)
Modalities:Cell therapy, Gene therapy, mAb, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Emery Pharma (Strategic partnership for end-to-end drug development services)
COMPETITION
Position:Niche Player
Competitors:Polpharma Biologics, Asymchem, Enzene Biosciences, EA Pharma
LEADERSHIP
Key Executives:
Tania Weiss - CEO
Beñat Mallavia - Chief Scientific Officer
LINKS
Website:marinbio.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Marin Biologic Laboratories. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.